Compare Humana Inc (HUM) vs State Street SPDR Bloomberg High Yield Bond ETF (JNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs State Street SPDR Bloomberg High Yield Bond ETF — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while State Street SPDR Bloomberg High Yield Bond ETF trades at $95.74. The key difference: Humana Inc pays a 0.92% dividend while State Street SPDR Bloomberg High Yield Bond ETF pays none, and Humana Inc is trading nearer its 52-week high, State Street SPDR Bloomberg High Yield Bond ETF nearer its low. Which is the better fit depends on your goals.
| HUM | JNK | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | Fixed Income |
52-Week High | $409.42 | $98.19 |
52-Week Low | $163.67 | $94.66 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
JNK trades at $95.81, up 0.21% today, with a bearish technical signal driven by moving averages. Key support sits at $95 and resistance at $96. The ETF provides high-yield bond exposure, with recent dividends of $0.52-$0.53 paid quarterly. News highlights focus on bond market volatility, inflation concerns, and AI-related credit risks impacting junk bonds.
Outlook is cautious due to rising Treasury yields and inflation fears pressuring high-yield bonds. Opportunities exist for income-seeking investors amid higher yields, but risks include Fed rate hike uncertainty and elevated oil prices affecting corporate credit. Investor sentiment is mixed, with inflows into bond ETFs offset by macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About State Street SPDR Bloomberg High Yield Bond ETF
JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →
